Gordon Cook

42PUBLICATIONS
164CO-AUTHORS
Ngā rongoā me ngā whakamaimoa o te Māori (Māori medicine and treatments)Medical bacteriologyMedical mycologyGene and molecular therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (42)

|Aug 24, 2026
Daratumumab, lenalidomide, and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: MAIA final survival analysis.

|May 05, 2026
Infections in patients receiving daratumumab for newly diagnosed multiple myeloma: a pooled analysis of MAIA and ALCYONE.

|Aug 20, 2025
Challenging the concept of functional high-risk myeloma through transcriptional and genetic profiling.

Sina A Beer, David A Cairns, Charlotte Pawlyn

|Feb 27, 2025
Daratumumab/lenalidomide/dexamethasone in transplant-ineligible newly diagnosed myeloma: MAIA long-term outcomes.

Thierry Facon, Philippe Moreau, Katja Weisel

|Dec 18, 2024
The UK consensus supporting effective introduction of novel treatments for multiple myeloma in the National Health Service.

Rakesh Popat, Supratik Basu, Sarah Henshaw

|Mar 19, 2024
Progression free survival of myeloma patients who become IFE-negative correlates with the detection of residual monoclonal free light chain (FLC) by mass spectrometry.

H V Giles, M T Drayson, B Kishore

Pageof 7

Frequent Collaborators

15 joint publications

Martin Kaiser

10 joint publications

David A Cairns

9 joint publications

Charlotte Pawlyn

5 joint publications

Hartmut Goldschmidt